BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 24259634)

  • 21. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae.
    Ariza-Heredia EJ; Patel R; Blumberg EA; Walker RC; Lewis R; Evans J; Sankar A; Willliams MD; Rogers J; Milano C; Razonable RR
    Transpl Infect Dis; 2012 Jun; 14(3):229-36. PubMed ID: 22624726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
    Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin.
    Dalgic N; Ceylan Y; Sancar M; Telhan L; Kafadar I; Cavusoglu H; Ceylan O; Hasim O
    Ann Trop Paediatr; 2009 Jun; 29(2):141-7. PubMed ID: 19460268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
    Russo A; Giuliano S; Ceccarelli G; Alessandri F; Giordano A; Brunetti G; Venditti M
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals.
    Mezzatesta ML; Gona F; Caio C; Petrolito V; Sciortino D; Sciacca A; Santangelo C; Stefani S
    Clin Microbiol Infect; 2011 Sep; 17(9):1444-7. PubMed ID: 21668577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.
    Gatti M; Raschi E; De Ponti F
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):65. PubMed ID: 31718688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin.
    Fotakopoulos G; Makris D; Chatzi M; Tsimitrea E; Zakynthinos E; Fountas K
    Acta Neurochir (Wien); 2016 Mar; 158(3):603-10; discussion 610. PubMed ID: 26801512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review.
    Segal-Maurer S; Mariano N; Qavi A; Urban C; Rahal JJ
    Clin Infect Dis; 1999 May; 28(5):1134-8. PubMed ID: 10452648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection.
    Medeiros GS; Rigatto MH; Falci DR; Zavascki AP
    Int J Antimicrob Agents; 2019 Feb; 53(2):152-157. PubMed ID: 30722960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases.
    Tängdén T; Enblad P; Ullberg M; Sjölin J
    Clin Infect Dis; 2011 Jun; 52(11):1310-6. PubMed ID: 21540208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae.
    Gaibani P; Lombardo D; Bartoletti M; Ambretti S; Campoli C; Giannella M; Tedeschi S; Conti M; Mancini R; Landini MP; Re MC; Viale P; Lewis RE
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1925-1931. PubMed ID: 31278562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
    Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.
    Won SY; Munoz-Price LS; Lolans K; Hota B; Weinstein RA; Hayden MK;
    Clin Infect Dis; 2011 Sep; 53(6):532-40. PubMed ID: 21865189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects.
    da Silva RM; Traebert J; Galato D
    Expert Opin Biol Ther; 2012 Jun; 12(6):663-71. PubMed ID: 22506862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-resistant Klebsiella oxytoca ventriculitis, successfully treated with intraventricular tigecycline: A case report.
    Soto-Hernández JL; Soto-Ramírez A; Pérez-Neri I; Angeles-Morales V; Cárdenas G; Barradas VA
    Clin Neurol Neurosurg; 2020 Jan; 188():105592. PubMed ID: 31760254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of intraventricular colistin utilization: A case series.
    Gilbert B; Morrison C
    J Crit Care; 2017 Aug; 40():161-163. PubMed ID: 28410511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
    Quinn AL; Parada JP; Belmares J; O'Keefe JP
    Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.